ID   SWA20
AC   CVCL_JZ76
SY   SWA-20
DR   Wikidata; Q54971232
RX   DOI=10.1016/S0169-5002(88)80032-1;
RX   Patent=EP0323802A2;
RX   PubMed=2839290;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 88030201.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Human cluster-5A antigen (sGP100) on small cell lung cancer.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
RX   DOI=10.1016/S0169-5002(88)80032-1;
RA   Stahel R.A., Waibel R., O'Hara C.J.;
RT   "Characterisation of small cell carcinoma surface membrane antigens by
RT   indirect immunofluorescence. Solid phase radioimmunoassay and
RT   immunoblotting.";
RL   Lung Cancer 4:111-114(1988).
//
RX   Patent=EP0323802A2;
RA   Stahel R.A., Waibel R.;
RT   "Monoclonal antibodies against, and cell surface antigen of, lung
RT   carcinoma.";
RL   Patent number EP0323802A2, 12-Jul-1989.
//
RX   PubMed=2839290;
RA   Waibel R., O'Hara C.J., Smith A., Stahel R.A.;
RT   "Tumor-associated membrane sialoglycoprotein on human small cell lung
RT   carcinoma identified by the IgG2a monoclonal antibody SWA20.";
RL   Cancer Res. 48:4318-4323(1988).
//